FUSEN PHARM (01652) announced that effective September 30, 2025, Mr. Shi Yongjin has resigned from his position as independent non-executive director and will no longer serve as chairman of the audit committee. Mr. Yu Haoming has been appointed as independent non-executive director and member of the audit committee, while Mr. Li Guodong has been appointed as chairman of the audit committee.